{"SLR NAME":"The effect of comorbid pulmonary diseases on the severity of COVID-19 patients: a systematic review and meta-analysis","References":[{"title1":"Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Assessment of clinical criteria for sepsis for the third international consensus definitions for sepsis and septic shock (sepsis-3)","References":[{"title3":"Hospital deaths in patients with sepsis from 2 independent cohorts"},{"title3":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care"},{"title3":"2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome"},{"title3":"Effectiveness of a hospital-wide educational programme for infection control to reduce the rate of health-care associated infections and related sepsis (ALERTS):methods and interim results [in German]"},{"title3":"The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure"},{"title3":"The Logistic Organ Dysfunction System: a new way to assess organ dysfunction in the intensive care unit"},{"title3":"Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement"},{"title3":"The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study"},{"title3":"The inconsistency of &quot;optimal&quot; cutpoints obtained using two criteria based on the receiver operating characteristic curve"},{"title3":"Prediction of critical illness during out-of-hospital emergency care"},{"title3":"APACHE:Acute Physiology and Chronic Health Evaluation: a physiologically based classification system"},{"title3":"Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited"},{"title3":"Cronbach's alpha"},{"title3":"Convergent and discriminant validation by the multitrait-multimethod matrix"},{"title3":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data"},{"title3":"Building multivariable regression models with continuous covariates in clinical epidemiology:with an emphasis on fractional polynomials"},{"title3":"Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics"},{"title3":"Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012"},{"title3":"Consensus on circulatory shock and hemodynamic monitoring: task force of the European Society of Intensive Care Medicine"},{"title3":"Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values"},{"title3":"The meaning and use of the area under a receiver operating characteristic (ROC) curve"},{"title3":"Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program"},{"title3":"Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia"},{"title3":"Risk-adjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system"},{"title3":"Systemic inflammatory response syndrome criteria in defining severe sepsis"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Comparison of trends in sepsis incidence and coding using administrative claims vs objective clinical data"},{"title3":"Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule"},{"title3":"Concept of PIRO as a new conceptual framework to understand sepsis"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the Angus implementation of the International Consensus Conference definition of severe sepsis"},{"title3":"Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study"}]},{"title2":"F. Al-Ghimlas. Personal communication: department of public health. 2020.","References":[]},{"title2":"Is ethnicity linked to incidence or outcomes of covid-19?","References":[]},{"title2":"Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers","References":[{"title3":"Comorbidities in COVID-19: outcomes in hypertensivecohort and controversies with renin angiotensin system blockers"},{"title3":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis"},{"title3":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. doi:10.1001/jamacardio.2020.1017. Published online March 27, 2020."},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China","References":[]},{"title2":"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest novel coronavirus outbreak in Wuhan China"},{"title3":"Report of novel coronavirus-infected pneumonia in China. Wuhan Municipal Health Commission. 2020. https://wjw.wuhan.gov.cn/front/web/showDetail/2020012009077. Accessed March 28th 2020"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan Municipal Health Commission. 2019. https://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989. Accessed March 28th 2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"National Health Commission of the People's Republic of China. https://www.nhc.gov.cn/xcs/yqtb/202004/82ca3a872c864abc80a538c0ec948f10.shtml. Accessed April 14th 2020."},{"title3":"Coronavirus disease (COVID-2019) situation reports. World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed April 14th 2020."},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 is suspected. (2020) World Health Organization. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed April 9th 2020."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan China"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Diagnosis and Treatment of Pneumonia Caused by SARS-COV-2 (version 7). National Health Commission of the People's Republic of China. https://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf. Accessed April 9th 2020."},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Clinical characteristics of 138 hospitalized patients with, novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA Score"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment"}]},{"title2":"Prevalence of asymptomatic SARS-CoV-2 infection","References":[{"title3":"Discussion on lesson learned from first wave of COVID-19 pandemic in Japan:from physician's point of view"},{"title3":"Urgent recommendations regarding the expansion of PCR tests, etc for COVID-19 infection control. Article in Japanese. https://www.covid19-jma-medical-expert-meeting.jp/topic/3243"},{"title3":"Science, technology, and innovation for the post-corona era. Article in Japanese. Japan Medical Association COVID-19 expert meeting. Accessed November 13, 2022. https://www.eaj.or.jp/eajlocal/wp-content/uploads/2021/10/eaj-report-proj-20210513-01.pdf"},{"title3":"Department of Immunology and Genomic Medicine. Kyoto University Graduate School of Medicine. Statement from Tasuku Honjo on COVID-19. Accessed November 13, 2022. https://www2.mfour.med.kyoto-u.ac.jp/en/index.html "},{"title3":"worldometer. COVID-19. Accessed November 7, 2022. https://wwwworldometers.info/coronavirus/"},{"title3":"Resurgence of SARS-CoV-2: detection by community viral surveillance"},{"title3":"Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis"},{"title3":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening"},{"title3":"Visualizing the data: information on COVID-19 infections. Accessed November 13, 2022. https://covid19.mhlw.go.jp/extensions/public/en/index.html"},{"title3":"Open data. Accessed November 13, 2022. https://wwwmhlwgojp/stf/covid-19/open-data_englishhtml "},{"title3":"COVID-19 AI and Simulation Project. Accessed November 13, 2022. https://www.covid19-ai.jp/en-us/ "},{"title3":"Results of Health, Labor and Welfare Science Research on PCR testing using saliva. Article in Japanese. Accessed November 13, 2022. https://wwwmhlwgojp/content/10906000/000635988pdf"},{"title3":"Saliva is a reliable and accessible source for the detection of SARS-CoV-2"},{"title3":"Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis"},{"title3":"Interpreting diagnostic tests for SARS-CoV-2"},{"title3":"To interpret the SARS-CoV-2 test, consider the cycle threshold value"},{"title3":"Mass screening of asymptomatic persons for severe acute respiratory syndrome coronavirus 2 using saliva"},{"title3":"About the Ct value of PCR of COVID-19 and type 2 infection"},{"title3":". Ct (cycle threshold) being used for PCR testing of SARS Covid-19. 280621. Accessed November 7, 2022. https://www.mtw.nhs.uk/foi/ct-cycle-threshold-being-used-for-pcr-testing-of-sars-covid-19-280621/"},{"title3":"Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020"},{"title3":". Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR. Accessed November 30, 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/926410/Understanding_Cycle_Threshold__Ct__in_SARS-CoV-2_RT-PCR_.pdf"},{"title3":"Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities"},{"title3":"Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China"},{"title3":"The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): a systematic review and meta-analysis"},{"title3":"Covid-19: Hong Kong government supplies reusable face masks to all residents"},{"title3":"Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2"}]},{"title2":"Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019: a retrospective cross-sectional study","References":[]},{"title2":"C-reactive protein levels in the early stage of COVID-19","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan. China: a descriptive study"},{"title3":"Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease"},{"title3":"Early diagnosis of pneumonia in severe stroke: clinical features and the diagnostic role of C-reactive protein"},{"title3":"Covid-19 diagnostic and therapeutic regimen (trial 7th, edition)"},{"title3":"China coronavirus: mild but infectious cases may make it hard to control outbreak. Report warms"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Emphasis and scientific evaluate the role of CT in the diagnosis and treatment of novel coronavirus pneumonia"},{"title3":"Pneumonia associated with 2019 novel coronavirus: can computed tomographic findings help predict the prognosis of the disease?"},{"title3":"Comparison of pre-and post-levothyroxine high-sensitivity C-reactive protein and fetuin-A levels in subclinical hypothyroidism"},{"title3":"Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers"},{"title3":"Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure"}]},{"title2":"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis","References":[{"title3":"Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis"},{"title3":"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis"}]},{"title2":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","References":[{"title3":" Coronavirus Disease 2019 (COVID-19) Situation Report-63 "},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Intergovernmental Panel on Climate Change, ed"},{"title3":"Neutrophils and neutrophil-lymphocyte ratio: inflammatory markers associated with intimal-media thickness of atherosclerosis"},{"title3":"Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer"},{"title3":"Estimating the mean and variance from the median, range, and the size of a sample"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19"},{"title3":"The clinical and chest CT features associated with severe and critical COVID-19 pneumonia"}]},{"title2":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19 complicated by acute pulmonary embolism"},{"title3":"ECMO and COVID-19. Experience from Paris. EuroELSO Webinar, https://www.euroelso.net/webinars/. Accessed April 3, 2020."},{"title3":"A novel device for evaluation of hemostatic function in critical care settings"},{"title3":"Interleukin 6 and haemostasis"},{"title3":"Regulation of tissue factor gene expression in monocytes and endothelial cells: thromboxane A2 as a new player"},{"title3":"Acute thrombotic vascular events complicating influenza-associated pneumonia"},{"title3":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"}]},{"title2":"Frequency and distribution of chest radiographic findings in COVID-19 positive patients","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China"},{"title3":"Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases"},{"title3":"Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection"},{"title3":"Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia"},{"title3":"Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review"},{"title3":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Chinese Society of Radiology. Radiological diagnosis of new coronavirus infected pneumonitis: Expert recommendation from the Chinese Society of Radiology (First edition)"},{"title3":"Coronavirus Disease 2019 (COVID-19): A Perspective from China"},{"title3":"Corona Virus International Public Health Emergencies: Implications for Radiology Management"},{"title3":"ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection | American College of Radiology"},{"title3":"Imaging the coronavirus disease COVID-19"},{"title3":"Glossary of terms for thoracic imaging"},{"title3":"Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS"},{"title3":"Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens"},{"title3":"Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19)"},{"title3":"Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients"},{"title3":"Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study"},{"title3":"Sensitivity of Chest CT for COVID-19: Comparison to RTPCR"},{"title3":"Follow-Up Study of 131 COVID-19 Discharged Patients: Is the Current Chinese Discharge Criteria Reliable? March 2020"},{"title3":"Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020"}]},{"title2":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China","References":[{"title3":"Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV"},{"title3":"Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission"},{"title3":"SARS: imaging of severe acute respiratory syndrome"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Avaiable from: https://clinicaltrials.gov/ct2/results?cond=Coronavirus&amp;term=&amp;cntry=&amp;state=&amp;city=&amp;dist=."},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis"},{"title3":"Corticosteroids and ARDS: A review of treatment and prevention evidence"},{"title3":"Fluid management in acute lung injury and ards"}]},{"title2":"COVID-19 and smoking: a systematic review of the evidence","References":[{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72.314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis"},{"title3":"COVID-19 and smoking: A systematic review of the evidence"},{"title3":"COVID-19 and smoking"},{"title3":"Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: A meta-analysis. medRxiv preprint. doi: https://doi.org/10.1101/2020.04.13.20063669"},{"title3":"The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis"},{"title3":"Schopfel J. Towards a Prague definition of grey literature. Twelfth International Conference on Grey Literature: Transparency in Grey Literature. Grey Tech Approaches to High Tech Issues. Prague, 6-7 December 2010, Dec 2010, Czech Republic. pp. 11-26. sic_00581570 [consultado30 Abr 2020]. Disponible en: https://archivesic.ccsd.cnrs.fr/sic_00581570/document"},{"title3":"The PRISMA Group, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement"},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration"},{"title3":"Meta-analysis in clinical trials"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America"},{"title3":"Evidence-based medicine chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Review Manager (RevMan) [programa informatico]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014."},{"title3":"Prevalence of underlying diseases in hospitalized patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Hu L, Chen S, Fu Y, Gao Z, Long H, Ren HW, et al. Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China. medRxiv preprint. doi: https://doi.org/10.1101/2020.03.25.20037721"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19"},{"title3":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China"},{"title3":"Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)"},{"title3":"Ma Ch, Gu J, Hou P, Zhang L, Bai Y, Guo Z, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: A systematic review and meta-analysis. medRxiv preprint doi: https://doi.org/10.1101/2020.03.17.20037572."},{"title3":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease"},{"title3":"Wu C, Hu X, Song J, Du Ch, Xu J, Yang D, et al. Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19). medRxiv preprint doi: https://doi.org/10.1101/2020.02.26.20028589."},{"title3":"Smoking, vaping and hospitalization for COVID-19"},{"title3":"COVID-19 with different severity: A multi-center study of clinical features"},{"title3":"Clinical feature of COVID-19 in elderly patients: A comparison with young and middle-aged patients"},{"title3":"Shu L, Wang X, Li M, Chen X, Shi L, Wu M, et al. Clinical characteristics of 545 cases confirmed COVID-19 in Wuhan Stadium Cabin Hospital. [consultado 1 May 2020]. Disponible en: https://ssrn.com/abstract=3552844 o http://dx.doi.org/102139/ssrn.3552844"},{"title3":"Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Qi D, Yan X, Tang X, Peng J, Yu Q, Feng L, et al. Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: A retrospective, descriptive, multiple-center study. medRxiv preprint. doi: https://doi.org/10.1101/2020.03.01.20029397"},{"title3":"Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang, Anhui, China"},{"title3":"CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 20203;69(13):382-386. doi: 10.15585/mmwr.mm6913e2."},{"title3":"Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: A preliminary report of the first 28 patients from the Korean Cohort Study on COVID-19"},{"title3":"Clinical features and treatment of COVID-19 patients in northeast Chongqing"},{"title3":"Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"Prediction for progression risk in patients with COVID-19 pneumonia: The CALL Score"},{"title3":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan"},{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"U.S. Department of Health and Human Services Center of Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health. Smoking Cessation. A report of the surgeon general. Atlanta, GA: 2020 [consultado 1 May 2020]. Disponible en: https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf"},{"title3":"Tobacco and waterpipe use increases the risk of suffering from COVID-19. World Health Organization (WHO) 2020 [consultado 1 May 2020]. Disponible en: http://www.emro.who.int/tfi/know-the-truth/tobacco-and-waterpipe-users-are-at-increased-risk-of-covid-19-infection.html"},{"title3":"Smoking Upregulates angiotensin-converting enzyme-2 receptor: A potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)"},{"title3":"Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization (WHO) [consultado 1 Mayo 2020]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it"}]},{"title2":"Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)","References":[{"title3":"New therapeutic targets for the prevention of infectious acute exacerbations of COPD: Role of epithelial adhesion molecules and inflammatory pathways"},{"title3":"Dysfunctional Immunity and Microbial Adhesion Molecules in Smoking-Induced Pneumonia"},{"title3":"Mitochondrial dysfunction in macrophages: A key to defective bacterial phagocytosis in COPD"},{"title3":"Understanding novel mechanisms of microbial pathogenesis in chronic lung disease: Implications for new therapeutic targets"},{"title3":"Inhaled corticosteroids and increased microbial load in COPD: Potential role of epithelial adhesion molecules"},{"title3":"Cigarette smoking and the occurrence of influenza:Systematic review"},{"title3":"Smoking and Influenza-associated Morbidity and Mortality: A Systematic Review and Meta-analysis"},{"title3":"Chronic Obstructive Pulmonary Disease (COPD)"},{"title3":"It takes two to tango: Cigarette smoke partners with viruses to promote emphysema"},{"title3":"Coronavirus Disease (COVID-19) Outbreak"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Comorbidities Workgroup of the Society for Research on Nicotine and Tobacco (SRNT) Treatment Network. Exploring Issues of Comorbid Conditions in People Who Smoke"},{"title3":"Trends in Cigarette Smoking Among Older Male Adults in China: An Urban-Rural Comparison"},{"title3":"Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: A population-level observational study"},{"title3":"Coronavirus Disease (COVID-19):Research and Statistics"},{"title3":"Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor"},{"title3":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade"},{"title3":"Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry"},{"title3":"Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure"},{"title3":"ACE2 Angiotensin I Converting Enzyme 2 [Homo Sapiens (Human)] Gene ID: 59272, Updated on 5-Mar-2020"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Heat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"Cross-species transmission of the newly identified coronavirus 2019-nCoV"},{"title3":"SARS (Severe Acute Respiratory Syndrome)"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Novel Coronavirus Structure Reveals Targets for Vaccines and Treatments"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Potential Mechanisms of Microbial Pathogens in Idiopathic Interstitial Lung Disease"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Susceptibility Analysis of COVID-19 in Smokers Based on ACE2"},{"title3":"Effect of shisha (waterpipe) smoking on lung functions and fractional exhaled nitric oxide (FeNO) among Saudi young adult shisha smokers"},{"title3":"IQOS exposure impairs human airway cell homeostasis: Direct comparison with traditional cigarette and e-cigarette"},{"title3":"E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells"},{"title3":"There can be smoke without fire: Warranted caution in promoting electronic cigarettes and heat not burn devices as a safer alternative to cigarette smoking"},{"title3":"Smoking or Vaping Increases Risks for Those with Coronavirus: NYC Mayor"}]},{"title2":"Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?","References":[{"title3":"Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Comment"},{"title3":"Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?"},{"title3":"Smoking and the risk of COVID-19 in a large observational population study"},{"title3":"National smoking rates correlate inversely with COVID-19 mortality"},{"title3":"Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis"}]},{"title2":"Current smoking is not associated with COVID-19","References":[]},{"title2":"Baseline Characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Asthma and COVID-19","References":[]},{"title2":"Does asthma make COVID-19 worse?","References":[{"title3":"SARS-CoV-2, ACE2 expression, and systemic organ invasion"},{"title3":"The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants"},{"title3":"Childhood Respiratory Conditions: Asthma"},{"title3":"Type I Interferon Susceptibility Distinguishes SARS-CoV-2, SARS-CoV"},{"title3":"Rhinovirus Infections in Individuals with Asthma Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19"},{"title3":"Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK"},{"title3":"Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity"},{"title3":"Mild/Moderate Asthma Network in Italy (MANI): A long-term observational study"},{"title3":"Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: Results from the Italian Severe Asthma Registry"},{"title3":"COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments"},{"title3":"The Global Impact of Asthma in Adult Populations"},{"title3":"Asthma and COVID-19: A dangerous liaison?"},{"title3":"Characterization of Severe Asthma Worldwide: Data from the International Severe Asthma Registry"},{"title3":"Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19"},{"title3":"Is asthma a risk factor for severe outcomes in COVID-19?"},{"title3":"Obesity and asthma"},{"title3":"Validation of the updated charlson comorbidity index (cci) for use in patients with diabetes or asthma: A comparison study"},{"title3":"Viral clearance after early corticosteroid treatment in patients with moderate or severe COVID-19"},{"title3":"Standardising PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to COVID-19: A pilot prospective study"},{"title3":"COVID-19-Related Lung Involvement at Different Time Intervals: Evaluation of Computed Tomography Images with Semiquantitative Scoring System and COVID-19 Reporting and Data System Scoring"},{"title3":"How COVID-19 interacts with interstitial lung disease"},{"title3":"COVID-19 severity scoring systems in radiological imaging:A review"},{"title3":"CIRCOLARE SULLE PROCEDURE SEMPLIFICATE PER GLI STUDI E I PROGRAMMI DI USO TERAPEUTICOCOMPASSIONEVOLE PER L'EMERGENZA DA COVID-19"},{"title3":"Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis"},{"title3":"The impact of SARS-CoV-2 transmission fear and COVID-19 pandemic on the mental health of patients with primary immunodeficiency disorders, severe asthma, and other high-risk groups"},{"title3":"COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence"},{"title3":"Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center"},{"title3":"Do the current guidelines for asthma pharmacotherapy encourage over-treatment?"},{"title3":"Management of asthma patients during the COVID-19 pandemic: Pathophysiological considerations to address the challenges"},{"title3":"Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic"},{"title3":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon"},{"title3":"A Case of Work-Related Donkey Milk Allergy"},{"title3":"Airway hyperresponsiveness in asthma: Lessons from in vitro model systems and animal models"},{"title3":"Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic's COVID-19 registry"},{"title3":"Characteristics of patients admitted to emergency department for asthma attack: A real-LIFE study"},{"title3":"Overuse of short-acting beta2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme"},{"title3":"Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients"},{"title3":"Mortality from COVID-19 in Patients with COPD: A US Study in the N3C Data Enclave"},{"title3":"Mechanical ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma"}]}]},{"title1":"Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series","References":[{"title2":"COVID-19","References":[]},{"title2":"Critical supply shortages - The need for ventilators and personal protective equipment during the covid-19 pandemic","References":[]},{"title2":"International comparisons of intensive care: informing outcomes and improving standards","References":[{"title3":"The birth of intensive care medicine: Bjorn Ibsen's records"},{"title3":"Demystifying critical care"},{"title3":"Variation in critical care services across North American and Western Europe"},{"title3":"Clinical review: international comparisons of critical care--lessons learned"},{"title3":"Levels of Critical Care for Adult Patients"},{"title3":"A unique snapshot of intensive care resources in Australia and New Zealand"},{"title3":"Effect of nurse-to-patient ratio in the intensive care unit on pulmonary complications and resource use after hepatectomy"},{"title3":"ICU nurse-to-patient ratio is associated with complications and resource use after esophagectomy"},{"title3":"Hospital mortality in relaiton to staff workload: a 4-year study in an adult intensive-care unit"},{"title3":"Standards for nurse staffing in critical care (updated 2010)"},{"title3":"Is it time to set minimum nurse staffing levels in English hospitals?"},{"title3":"The association of registered nurse staffing levels and patient outcomes: systematic review and meta-analysis"},{"title3":"Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations"},{"title3":"Decisions made by critical care nurses during mechanical ventilation and weaning in an Australian intensive care unit"},{"title3":"The effect of multidisciplinary care teams on intensive care unit mortality"},{"title3":"Nighttime intensivist staffing and mortality among critically ill patients"},{"title3":"Improving the comparability of cancer registry treatment data and proposals for a new national minimum dataset"},{"title3":"Standardization of terminology, definitions, and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group"},{"title3":"Standardization of terminology of virologic response in the treatment of chronic hepatitis C: panel recommendations"},{"title3":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"Has mortality from acute respiratory distress syndrome decreased over time?"},{"title3":"Intensive care medicine in Europe"},{"title3":"Variation in Critical Care Beds Per Capita in the United States: Implications for Pandemic and Disaster Planning"},{"title3":"Critical care and the global burden of critical illness in adults"},{"title3":"Japan's Universal and Affordable Health Care: Lessons for the United States"},{"title3":"The variability of critical care bed numbers in Europe"},{"title3":"Is there a starling curve for intensive care?"},{"title3":"Comparison of Medical Admissions to Intensive Care Units in the United States and United Kingdom"},{"title3":"Evaluation of modernisation of adult critical care services in England: time series and cost effectiveness analysis"},{"title3":"Mortality among appropriately referred patients refused admission to intensive-care units"},{"title3":"Consequences of discharges from intensive care at night"},{"title3":"Disease and disadvantage in the United States and in England"},{"title3":"Worldwide demand for critical care"},{"title3":"A comparison of intensive care unit utilization in Alberta and western Massachusetts"},{"title3":"Refusal of ICU Admission Due to a Full Unit: Impact on Mortality"},{"title3":"Survival of critically ill patients hospitalized in and out of intensive care units under paucity of intensive care unit beds"},{"title3":"Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis"},{"title3":"Intensive care unit bed availibility and outcomes for hospitalized patients with sudden clinical deterioration"},{"title3":"The implications of long-term acute care hospital transfer practices for measures of in-hospital mortality and length of stay"},{"title3":"Three-year outcomes for Medicare beneficiaries who survive intensive care"},{"title3":"Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs"},{"title3":"The changing epidemiology of mechanical ventilation: a population-based study"},{"title3":"Regionalization of medical critical care: what can we learn from the trauma experience?"},{"title3":"A cross-cultural comparison of critical care delivery: Japan and the United States"},{"title3":"Critical Care Rationing: International Comparisons"},{"title3":"Uncharted Paths"},{"title3":"Reorganizing Adult Critical Care Delivery: the role of regionalization, telemedicine, and community outreach"},{"title3":"Reduction in critical mortality in urban mass casualty incidents: analysis of triage, surge, and resource use after the London bombings on July 7, 2005"},{"title3":"Inter-hospital transfers of acutely ill adults in Scotland"},{"title3":"Pro/con debate: Do the benefits of regionalized critical care delivery outweigh the risks of interfacility patient transport?"},{"title3":"Rationing in the intensive care unit"},{"title3":"Physicians' perceptions and attitudes regarding inappropriate admissions and resource allocation in the intensive care setting"},{"title3":"Intensive care unit admitting patterns in the veterans affairs health care system"},{"title3":"European attitudes towards ethical problems in intensive care medicine: results of an ethical questionnaire"},{"title3":"Use of intensive care services during terminal hospitalizations in England and the United States"},{"title3":"End-of-life practices in European intensive care units: the Ethicus Study"},{"title3":"A review and analysis of intensive care medicine in the least developed countries"},{"title3":"Critical care in resource-poor settings: Lessons learned and future directions"},{"title3":"Katrina, the Tsunami, and Point-of-Care Testing"},{"title3":"The epidemiology of Hajj-related critical illness: lessons for deployment of temporary critical care services"},{"title3":"Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine"},{"title3":"Mortality after fluid bolus in African children with severe infection"}]},{"title2":"Fair allocation of scarce medical resources in the time of covid-19","References":[{"title3":"Potential association between COVID-19 mortality and health-care resource availability"},{"title3":"Fair allocation of scarce medical resources in the time of Covid-19"},{"title3":"Whose life to save? Scarce resources allocation in the COVID-19 outbreak"},{"title3":"The toughest triage:allocating ventilators in a pandemic"},{"title3":"A framework for rationing ventilators and critical care beds during the COVID-19 pandemic"},{"title3":"Who gets the ventilator? Important legal rights in a pandemic"},{"title3":"Online panels in social science research: Expanding sampling methods beyond Mechanical Turk"},{"title3":"Educational Attainment in the United States: 2018"},{"title3":"Real Median Household Income in the United States [MEHOINUSA672N]"},{"title3":"The latest Gallup figures report an equal split among the three options"},{"title3":"The psychology of sunk cost"},{"title3":"Escalation and de-escalation of commitment in response to sunk costs: the role of budgeting in mental accounting"},{"title3":"Anomalies: the Endowment effect, loss aversion, and status quo bias"},{"title3":"Omission and commission in judgment and choice"},{"title3":"Availability: a heuristic for judging frequency and probability"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with covid-19 in Washington State","References":[]},{"title2":"Clinical characteristics of covid-19 in New York City","References":[{"title3":"COVID-19 Map"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Aki in hospitalized patients with and without COVID-19: a comparison study"},{"title3":"Aki in hospitalized patients with COVID-19"},{"title3":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction"},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"Thrombosis in hospitalized patients with COVID-19 in a new York City health system"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy"},{"title3":"States reporting cases of COVID-19 to CDC"},{"title3":"Defining the Epidemiology of Covid-19 - Studies Needed"},{"title3":"R: a language and environment for statistical computing. R found STAT comput Vienna, Austria; R foundation for statistical computing"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"SARS-CoV-2 infection among travelers returning from Wuhan, China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 in critically Ill patients in the seattle region - case series"},{"title3":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"}]},{"title2":"Covid-19 in critically ill patients in the Seattle region - case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region","References":[]},{"title2":"Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv. 2020.","References":[]},{"title2":"The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients","References":[]},{"title2":"NYS Department of Health. NYS Health Profiles - New York Presbyterian - Columbia Presbyterian Center 2020.","References":[]},{"title2":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","References":[{"title3":"A New Vision for the National Institutes of Health"},{"title3":"SQLGEN: a framework for rapid client-server database application development"},{"title3":"WebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databases"},{"title3":"Model-driven development of Web applications: the Auto Web system"},{"title3":"Value of Hosted Clinical Data Environments"},{"title3":"A comparison study: paper-based versus web-based data collection and management"}]},{"title2":"Algorithm AS 217: Computation of the dip statistic to test for unimodality","References":[]},{"title2":"Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality","References":[{"title3":"Insights into the interaction between influenza virus and pneumococcus"},{"title3":"Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza"},{"title3":"Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases"},{"title3":"Increased incidence of co-infection in critically ill patients with influenza"},{"title3":"Koch RM, Kox M, de Jonge MI, van der Hoeven JG, Ferwerda G, Pickkers P: Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU. Shock 2016."},{"title3":"Post-infectious immune suppression: a new paradigm of severe infections"},{"title3":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study"},{"title3":"Influenza-Associated Aspergillosis in Critically Ill patients"},{"title3":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness"},{"title3":"Invasive aspergillosis associated with severe influenza infections"},{"title3":"Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts"},{"title3":"Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza"},{"title3":"Reactivation of multiple viruses in patients with sepsis"},{"title3":"Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4"},{"title3":"The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. on behalf of the working group on sepsis-related problems of the european society of intensive care medicine"},{"title3":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group"},{"title3":"Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT)"},{"title3":"Innate immune evasion strategies of influenza viruses"},{"title3":"Factors associated with poor outcomes among adults hospitalized for influenza in France: a three-year prospective multicenter study"},{"title3":"Obstructive sleep apnea: implications for cardiac and vascular disease"},{"title3":"Influenza activity - United States, 2015-16 season and Composition of the 2016-17 Influenza Vaccine"},{"title3":"Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D et al: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014(4):CD008965."},{"title3":"Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data"},{"title3":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis"},{"title3":"Influenza a virus facilitates Streptococcus pneumoniae transmission and disease"},{"title3":"Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection"},{"title3":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection"},{"title3":"Invasive aspergillosis complicating pandemic influenza a (H1N1) infection in severely immunocompromised patients"},{"title3":"Isolation of Aspergillus in three 2009 H1N1 influenza patients"},{"title3":"(H1N1) complicated by invasive aspergillosis in non-severely immunocompromised patients"},{"title3":"Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis"},{"title3":"Pulmonary aspergillosis in non-immunocompromised patient with acute respiratory distress syndrome during a (H1N1) infection"},{"title3":"Pandemic 2009 influenza a(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients"},{"title3":"Personalized medicine in influenza: a bridge too far or the near future?"},{"title3":"Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza a"},{"title3":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States"}]},{"title2":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain","References":[{"title3":"Pandemic (H1N1) 2009. Update 62"},{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009"},{"title3":"Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009"},{"title3":"Situation Report. Pandemic Influenza (H1N1) 2009"},{"title3":"CDC protocol of realtime RTPCR for influenza A (H1N1). Geneva: World Health Organization, April 2009"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults"},{"title3":"Viral pneumonia due to influenza and parainfluenza viruses and adenoviruses"},{"title3":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure"},{"title3":"Vigilancia de la gripe en Espana"},{"title3":"Life-threatening respiratory failure from H1N1 influenza 09 (human swinw influenza)"},{"title3":"Influenza A virus infection and pulmonary microthormboembolism"},{"title3":"Seasonal influenza in adults and children- diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Disease society of America"},{"title3":"Update on avian influenza A (H5N1) virus infection in humans"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"}]},{"title2":"Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness","References":[]},{"title2":"Associations between prolonged intubation and developing post-extubation dysphagia and aspiration pneumonia in non-neurologic critically ill patients","References":[{"title3":"The incidence of dysphagia following endotracheal intubation: a systematic review"},{"title3":"Dysphagia after stroke: incidence, diagnosis, and pulmonary complications"},{"title3":"Complications and consequences of endotracheal intubation and tracheotomy: a prospective study of 150 critically ill adult patients"},{"title3":"Laryngeal complications of prolonged intubation"},{"title3":"Long-term complications of artificial airways"},{"title3":"Alteration in swallowing reflex after extubation in intensive care unit patients"},{"title3":"Laryngeal injury from prolonged intubation: a prospective analysis of contributing factors"},{"title3":"Routine fiberoptic endoscopic evaluation of swallowing following prolonged intubation: implications for management"},{"title3":"Incidence and impact of dysphagia in patients receiving prolonged endotracheal intubation after cardiac surgery"},{"title3":"Postextubation fiberoptic endoscopic evaluation of swallowing after prolonged endotracheal intubation: a randomized, prospective trial"},{"title3":"Swallowing disorders post orotracheal intubation in the elderly"},{"title3":"Swallowing dysfunction after cardiac operations. Associated adverse outcomes and risk factors including intraoperative transesophageal echocardiography"},{"title3":"Risk of dysphagia after transesophageal echocardiography during cardiac operations"},{"title3":"Consequence of dysphagia in the hospitalized patient: impact on prognosis and hospital resources"},{"title3":"Post-extubation dysphagia is associated with longer hospitalization in survivors of critical illness with neurologic impairment"},{"title3":"Postextubation dysphagia is persistent and associated with poor outcomes in survivors of critical illness"},{"title3":"Duration of oral endotracheal intubation is associated with dysphagia symptoms in acute lung injury patients"},{"title3":"Aspiration pneumonia and dysphagia in the elderly"},{"title3":"ICU-acquired swallowing disorders"},{"title3":"The videofluorographic swallowing study"},{"title3":"Oropharyngeal dysphagia after cardiac operations"},{"title3":"Routine evaluation for aspiration after thoracotomy for pulmonary resection"},{"title3":"A penetration-aspiration scale"},{"title3":"Quantifying swallowing function after stroke: a functional dysphagia scale based on videofluoroscopic studies"},{"title3":"A new Simplified Acute Physiology Score (SAPS II) based on a European/ North American multicenter study"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine"},{"title3":"Prolonged swallowing time in dysphagic Parkinsonism patients with aspiration pneumonia"},{"title3":"Clinical study of aspiration pneumonia in stroke patients"},{"title3":"Healthcare-associated pneumonia and aspiration pneumonia"},{"title3":"Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study"},{"title3":"Paresis acquired in the intensive care unit: a prospective multicenter study"},{"title3":"ICU-acquired weakness and recovery from critical illness"},{"title3":"Diagnosis and treatment of postextubation dysphagia: results from a national survey"},{"title3":"Inter- and intrajudge reliability of a clinical examination of swallowing in adults"},{"title3":"Early assessments of dysphagia and aspiration risk in acute stroke patients"},{"title3":"Factors associated with swallowing assessment after oral endotracheal intubation and mechanical ventilation for acute lung injury"},{"title3":"Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia"},{"title3":"Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior?"},{"title3":"Prospective, randomized outcome study of endoscopy versus modified barium swallow in patients with dysphagia"}]},{"title2":"Neurologic features in severe SARS-CoV-2 Infection","References":[]},{"title2":"Virtually perfect? Telemedicine for covid-19","References":[]}]},{"title1":"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019","References":[{"title2":"Covid -19 in critically ill patients in the Seattle region : case series.","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"and the Northwell COVID-19 Research Consortium: Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study.","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Pandemic 2009 influenza A in Argentina.","References":[{"title3":"The second wave of 2009 pandemic influenza A (H1N1) in New Zealand, January-October 2010"},{"title3":"Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity"},{"title3":"Spatial and temporal characteristics of the 2009 A/H1N1 influenza pandemic in Peru"},{"title3":"Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11"},{"title3":"Did socio-ecological factors drive the spatiotemporal patterns of pandemic influenza A (H1N1)"},{"title3":"A space-time permutation scan statistic for disease outbreak detection"},{"title3":"The clustering and transmission dynamics of pandemic influenza A (H1N1) 2009 cases in Hong Kong"},{"title3":"Influenza virus transmission is dependent on relative humidity and temperature"},{"title3":"Ecological factors associated with pandemic influenza A (H1N1) hospitalization rates in California, USA: a geospatial analysis"},{"title3":"Determinants of the spatiotemporal dynamics of the 2009 H1N1 pandemic in Europe: implications for real-time modelling"},{"title3":"Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 southern hemisphere countries"},{"title3":"Efecto del cierre de las escuelas sobre el brote de influenza A H1N1 en Tierra del Fuego, Argentina"},{"title3":"Avian influenza A (H5N1) age distribution in humans"},{"title3":"Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the southern hemisphere: Argentina, Australia, Chile, New Zealand and South Africa"},{"title3":"The spatiotemporal diffusion of pandemic influenza (H1N1)2009 in Hong Kong"},{"title3":"Influenza A (H1N1) transmission by road traffic between cities and towns"}]},{"title2":"Critically ill patients with 2009 influenza A(H1N1) in Mexico.","References":[]},{"title2":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.","References":[]},{"title2":"Mortality rates for patients with acute lung injury/ARDS have decreased over time.","References":[]},{"title2":"Respiratory support in novel coronavirus disease (COVID-19) patients, with a focus on resource-limited settings.","References":[]},{"title2":"With Ventilators Running Out, Doctors Say the Machines Are Overused for Covid-19. STATnewscom.","References":[]},{"title2":"Some Doctors Question Wisdom of Using Ventilators on Coronavirus Patients. San Francisco Chronicle.","References":[]},{"title2":"Ventilators Are No Panacea for Critically Ill COVID-19 Patients. National Public Radio.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]}]},{"title1":"Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain","References":[{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[]},{"title2":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"Clinical characteristics of COVID-19 in New York city","References":[{"title3":"COVID-19 Map"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Aki in hospitalized patients with and without COVID-19: a comparison study"},{"title3":"Aki in hospitalized patients with COVID-19"},{"title3":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction"},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"Thrombosis in hospitalized patients with COVID-19 in a new York City health system"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy"},{"title3":"States reporting cases of COVID-19 to CDC"},{"title3":"Defining the Epidemiology of Covid-19 - Studies Needed"},{"title3":"R: a language and environment for statistical computing. R found STAT comput Vienna, Austria; R foundation for statistical computing"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"SARS-CoV-2 infection among travelers returning from Wuhan, China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 in critically Ill patients in the seattle region - case series"},{"title3":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","References":[]},{"title2":"Variation in COVID-19 hospitalizations and deaths across New York City boroughs","References":[]},{"title2":"Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): a nationwide analysis of China","References":[]},{"title2":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","References":[{"title3":"WHO. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"title3":"WHO. WHO coronavirus disease 2019 (covid-19) situation report-101. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200430-sitrep-101-covid-19.pdf?sfvrsn=2ba4e093_2."},{"title3":"The UK's pandemic influenza research portfolio: a model for future research on emerging infections"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection"},{"title3":"WHO. WHO preliminary clinical description of severe acute respiratory syndrome. 2003.https://www.who.int/csr/sars/clinical/en/."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to covid-19 in Italy"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area"},{"title3":"Clarification of mortality rate and data in abstract, results, and table 2"},{"title3":"Conolly A, Craig S. Health survey for England 2018: overweight and obesity in adults and children. 2019. https://files.digital.nhs.uk/52/FD7E18/HSE18-Adult-Child-Obesity-rep.pdf."},{"title3":"Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK"},{"title3":"Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)"},{"title3":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Host susceptibility to severe influenza A virus infection"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy"},{"title3":"ICNARC. ICNARC report on COVID-19 in critical care. 2020:1-9. https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports."},{"title3":"ISARIC4C. ISARIC Coronavirus Clinical Characterisation Consortium. 2020. https://isaric4c.net/."},{"title3":"GOV.UK. New and Emerging Respiratory Virus Threats Advisory Group. 2020. https://www.gov.uk/government/groups/new-and-emerging-respiratory-virus-threats-advisory-group."},{"title3":"GOV.UK. Scientific Advisory Group for Emergencies. 2020. https://www.gov.uk/government/groups/scientific-advisory-group-for-emergencies-sage-coronavirus-covid-19-response."},{"title3":"GOV.UK. Scientific Pandemic Influenza Group on Modelling. 2020. https://www.gov.uk/government/groups/scientific-pandemic-influenza-subgroup-on-modelling."}]},{"title2":"International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC). COVID-19 Core Case Report Form. Acute Respiratory Infection Clinical Characterisation Data Tool","References":[]},{"title2":"Research electronic data capture (REDCap):a metadata-driven methodology and workflow process for providing translational research informatics support","References":[{"title3":"A New Vision for the National Institutes of Health"},{"title3":"SQLGEN: a framework for rapid client-server database application development"},{"title3":"WebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databases"},{"title3":"Model-driven development of Web applications: the Auto Web system"},{"title3":"Value of Hosted Clinical Data Environments"},{"title3":"A comparison study: paper-based versus web-based data collection and management"}]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"Estudio Nacional de Sero-Epidemiologia de la Infeccion por SARS-Cov-2 en Espana","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Sex differences in immune responses","References":[{"title3":"Sex Differences in the Adult Human Brain: Evidence from 5216 UK Biobank Participants"},{"title3":"X-factors in human disease: impact of gene content and dosage regulation"},{"title3":"Sex and gender: modifiers of health, disease, and medicine"},{"title3":"High expression of the mammalian X chromosome in brain"},{"title3":"Population-wide analysis of differences in disease progression patterns in men and women"},{"title3":"Sex Differences in Neurodegeneration: The Role of the Immune System in Humans"},{"title3":"Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging"},{"title3":"Gender differences in predictors of mortality in nursing home residents with AD"},{"title3":"Impact of Gender Differences on the Outcome of Alzheimer's Disease"},{"title3":"Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study"},{"title3":"Cognitive Performance in Subjects With Multiple Sclerosis Is Robustly Influenced by Gender in Canonical-Correlation Analysis"},{"title3":"Subcortical atrophy and cognition: sex effects in multiple sclerosis"},{"title3":"Sex-related factors in multiple sclerosis susceptibility and progression"},{"title3":"Sex specific cognitive differences in Parkinson disease"},{"title3":"Gender differences in Parkinson's disease"},{"title3":"Incidence of dementia in the oldest-old and its relationship with age: The Monzino 80-plus population-based study"},{"title3":"Effects of gender in amyotrophic lateral sclerosis"},{"title3":"Sex Biased Gene Expression Profiling of Human Brains at Major Developmental Stages"},{"title3":"Inflammation in neurodegenerative disease-a double-edged sword"},{"title3":"The impact of systemic infection on the progression of neurodegenerative disease"},{"title3":"Microglia in neurodegenerative disease"},{"title3":"Sex differences and similarities in the neuroimmune response to central administration of poly I:C"},{"title3":"The Lancet Commission on Dementia Prevention, Intervention, and Care: a call for action"},{"title3":"Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease"},{"title3":"Where are all the female participants in Sports and Exercise Medicine research? European Journal of Sport Science"},{"title3":"Biological Sex: A Potential Moderator of Physical Activity Efficacy on Brain Health"},{"title3":"Exercise and the Aging Brain: Considerations for Sex Differences"},{"title3":"The Role of Sex in Memory Function: Considerations and Recommendations in the Context of Exercise"},{"title3":"Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence"},{"title3":"Total daily physical activity and the risk of AD and cognitive decline in older adults"},{"title3":"The effects of cardiovascular exercise on human memory: a review with meta-analysis"},{"title3":"Dose-response relationship between exercise and cognitive function in older adults with and without cognitive impairment: A systematic review and meta-analysis"},{"title3":"Effects of chronic exercise interventions on executive function among children and adolescents: a systematic review with meta-analysis"},{"title3":"Exercise interventions for cognitive function in adults older than a systematic review with meta-analysis"},{"title3":"Aerobic exercise, cardiorespiratory fitness, and the human hippocampus"},{"title3":"The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials"},{"title3":"Estimating the lifetime risk of dementia in the Canadian elderly population using cross-sectional cohort survival data"},{"title3":"Systematic review and meta-analysis investigating moderators of long-term effects of exercise on cognition in healthy individuals"},{"title3":"Effects of aerobic exercise on mild cognitive impairment: a controlled trial"},{"title3":"Physical activity and risk of cognitive decline: a meta-analysis of prospective studies"},{"title3":"Sex differences in exercise efficacy to improve cognition: A systematic review and meta-analysis of randomized controlled trials in older humans"},{"title3":"Sex differences in aerobic exercise efficacy to improve cognition: A systematic review and meta-analysis of studies in older rodents"},{"title3":"Low-intensity daily walking activity is associated with hippocampal volume in older adults"},{"title3":"Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Abeta Pathology in Non-demented Individuals"},{"title3":"Sex-Specific Relationship Between Long-Term Maintenance of Physical Activity and Cognition in the Health ABC Study: Potential Role of Hippocampal and Dorsolateral Prefrontal Cortex Volume"},{"title3":"Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise"},{"title3":"Demographic and psychosocial correlates of physical activity in late life"},{"title3":"Gender differences in physical activity and walking among older adults"},{"title3":"The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease"},{"title3":"Muscle as an endocrine organ: focus on muscle-derived interleukin-6"},{"title3":"Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise"},{"title3":"Exercise and Toll-like receptors"},{"title3":"Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?"},{"title3":"Regular tai chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells"},{"title3":"Effect of exercise training intensity on murine T-regulatory cells and vaccination response"},{"title3":"Sex differences in immune responses"},{"title3":"The X chromosome and sex-specific effects in infectious disease susceptibility"},{"title3":"Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo "},{"title3":"The potential of endurance exercise-derived exosomes to treat metabolic diseases"},{"title3":"Exercise is the real polypill"},{"title3":"Integrative biology of exercise"},{"title3":"Exercise hormone irisin is a critical regulator of cognitive function"},{"title3":"Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function"},{"title3":"Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus"},{"title3":"VEGF is necessary for exercise-induced adult hippocampal neurogenesis"},{"title3":"Lactate Mediates the Effects of Exercise on Learning and Memory through SIRT1-Dependent Activation of Hippocampal Brain-Derived Neurotrophic Factor (BDNF)"},{"title3":"Maximal lactate steady state in running mice: effect of exercise training"},{"title3":"Exercise plasma boosts memory and dampens brain inflammation via clusterin"},{"title3":"Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain"},{"title3":"Exercise-Induced Activated Platelets Increase Adult Hippocampal Precursor Proliferation and Promote Neuronal Differentiation"},{"title3":"Exercise as a mean to control low-grade systemic inflammation"},{"title3":"Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations"},{"title3":"Role of myokines in exercise and metabolism"},{"title3":"Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content"},{"title3":"IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle"},{"title3":"Interleukin-6 in acute exercise and training: what is the biological relevance?"},{"title3":"Searching for the exercise factor: is IL-6 a candidate?"},{"title3":"The role of interleukin-6 signaling in nervous tissue"},{"title3":"Soluble receptors for cytokines and growth factors: generation and biological function"},{"title3":"Inflammatory blockade restores adult hippocampal neurogenesis"},{"title3":"Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells"},{"title3":"Astrocyte-derived interleukin-6 promotes specific neuronal differentiation of neural progenitor cells from adult hippocampus"},{"title3":"Influence of sex on cytokines, heat shock protein and oxidative stress markers in response to an acute total body resistance exercise protocol"},{"title3":"Sex-specific variation in signaling pathways and gene expression patterns in human leukocytes in response to endotoxin and exercise"},{"title3":"Sexual dimorphism of physical activity on cognitive aging: Role of immune functioning"},{"title3":"A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis"},{"title3":"The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion"},{"title3":"Is irisin the new player in exercise-induced adaptations or not? A update"},{"title3":"Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-athletes and are associated with bone density and strength estimates"},{"title3":"A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis"},{"title3":" , , , , , Thewonder exerkines:novel insights: a critical state-of-the-art review. Molecular and Cellular Biochemistry. 2021."},{"title3":"Muscles, exercise and obesity: skeletal muscle as a secretory organ"},{"title3":" , , , , , , .,Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway, Cell metabolism 2013;18."},{"title3":"Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males"},{"title3":"Alpha-2 macroglobulin is genetically associated with Alzheimer disease"},{"title3":"Origins, potency, and heterogeneity of skeletal muscle fibro-adipogenic progenitors: time for new definitions"},{"title3":"Single-cell transcriptional profiles in human skeletal muscle"},{"title3":"The impact of sex on gene expression across human tissues"},{"title3":"Skeletal muscle methylome and transcriptome integration reveals profound sex differences related to muscle function and substrate metabolism"},{"title3":"Toll-like receptor function and signaling"},{"title3":"Toll-like receptors-taking an evolutionary approach"},{"title3":"Toll-like receptors and innate immunity"},{"title3":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors"},{"title3":"Toll pathway-dependent blockade of CD4+CD25+T cell-mediated suppression by dendritic cells"},{"title3":"Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4"},{"title3":"The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men"},{"title3":"Influence of exercise training and age on CD14+cell-surface expression of toll-like receptor 2 and 4"},{"title3":"The physiological regulation of toll-like receptor expression and function in humans"},{"title3":"TLR7 escapes X chromosome inactivation in immune cells"},{"title3":"Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation"},{"title3":"TLR7 ligands induce higher IFN-alpha production in females"},{"title3":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1"},{"title3":"Effects of age, gender, and immunosuppressive agents on in vivo toll-like receptor pathway responses"},{"title3":"Biological sex affects vaccine efficacy and protection against influenza in mice"},{"title3":"Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: A possible mechanism for gender-based differences in endotoxic shock susceptibility"},{"title3":"Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice"},{"title3":"Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals"},{"title3":"TLR activation induces TNF-alpha production from adult neural stem/progenitor cells"},{"title3":"Preferential expression and function of Toll-like receptor 3 in human astrocytes"},{"title3":"Toll-like receptors in central nervous system glial inflammation and homeostasis"},{"title3":"The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA"},{"title3":"Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease"},{"title3":"Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis"},{"title3":"Role of toll-like receptor signalling in Abeta uptake and clearance"},{"title3":"Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits"},{"title3":"Non-cell-autonomous Neurotoxicity of alpha-synuclein Through Microglial Toll-like Receptor 2"},{"title3":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease"},{"title3":"Pathological alpha-synuclein exacerbates the progression of Parkinson's disease through microglial activation"},{"title3":"Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-kappaB signaling pathway"},{"title3":"Neuroprotective Effects of Endurance Exercise Against High-Fat Diet-Induced Hippocampal Neuroinflammation"},{"title3":"Effects of Toll-like receptor 4 inhibition on spatial memory and cell proliferation in male and female adult and aged mice"},{"title3":"Toll-like receptors modulate adult hippocampal neurogenesis"},{"title3":"Toll-like receptor 4 differentially regulates adult hippocampal neurogenesis in an age- and sex-dependent manner"},{"title3":"Evidence for a developmental role for TLR4 in learning and memory"},{"title3":"Young and aged TLR4 deficient mice show sex-dependent enhancements in spatial memory and alterations in interleukin-1 related genes"},{"title3":"The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation"},{"title3":"Sexually Dimorphic Role of Toll-like Receptor 4 (TLR4) in High Molecular Weight Hyaluronan (HMWH)-induced Anti-hyperalgesia"},{"title3":"Sex as a Biological Variable: A 5-Year Progress Report and Call to Action"},{"title3":"Transcriptomic profiling of skeletal muscle adaptations to exercise and inactivity"}]},{"title2":"Hypertension and COVID-19","References":[{"title3":"WHO Director-General's opening remarks at the media briefing on COVID19 -March 2020"},{"title3":"Hypertension and COVID-19: A public health perspective"},{"title3":"COVID-19 - A vascular disease"},{"title3":"Post-acute COVID-19 syndrome"},{"title3":"Risk factors for COVID-19 in patients with hypertension"},{"title3":"COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study"},{"title3":"Hypertension and COVID-19 : ongoing controversies"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"World Health Organization. Clinical management of COVID-19 : interim guidance, 27 May 2020. World Health Organization; 2020."},{"title3":"National Institutes of Health. ATP III guidelines at-a-glance quick desk reference. NIH publication. 2001 May:01-3305."},{"title3":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study"},{"title3":"European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement"},{"title3":"Epidemiological and clinical profile of COVID-19 patients admitted in a tertiary care hospital in Western India"},{"title3":"Epidemiological profile of SARS-CoV-2 among selected regions in Ghana: A cross-sectional retrospective study"},{"title3":"Trends and clinico-epidemiological profile of COVID-19 patients at a designated COVID-19 hospital in Delhi, North India"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"},{"title3":"Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis"},{"title3":"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis"},{"title3":"Bhandari S, Singh A, Sharma R, Rankawat G, Banerjee S, Gupta V, Dube A, et al. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study. J Assoc Physicians India. 2020:13-19."},{"title3":"Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait"},{"title3":"Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India"},{"title3":"Vascular dysfunction of COVID-19 is partially reverted in the long-term"},{"title3":"Follow-up study on COVID-19 survivors one year after discharge from hospital"},{"title3":"Post-covid syndrome in individuals admitted to hospital with COVID-19 : retrospective cohort study"},{"title3":"Follow-up study on serum Cholesterol profiles and potential sequelae in recovered COVID-19 patients"},{"title3":"COVID-19: the vasculature unleashed"},{"title3":"Assessment of autonomic nervous system dysfunction in the early phase of infection with SARS-CoV-2 virus"},{"title3":"Arterial stiffness, cardiovagal baroreflex sensitivity and postural blood pressure changes in older adults: the Rotterdam Study"}]},{"title2":"Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study","References":[{"title3":"Mortality associated with influenza and respiratory syncytial virus in the United States"},{"title3":"Influenza-associated hospitalizations in the United States"},{"title3":"Statement on influenza vaccination for the 2008-2009 season: an Advisory Committee Statement (ACS)"},{"title3":"Intensive-care patients with severe novel influenza A (H1N1) virus infection:Michigan, June 2009"},{"title3":"Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus"},{"title3":"Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus"},{"title3":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California"},{"title3":"The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis"},{"title3":"Obesity and respiratory diseases"},{"title3":"The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies"},{"title3":"Prevalence and trends in obesity among US adults, 1999-2008"},{"title3":"Prevalence of class I, II and III obesity in Canada"},{"title3":"Sample design of the national population health survey"},{"title3":"Canadian community health survey:methodological overview"},{"title3":"Self-reported weight and height: implications for obesity research"},{"title3":"Self-reported weight and height"},{"title3":"Estimates of obesity based on self-report versus direct measures"},{"title3":"Influenza and the rates of hospitalization for respiratory disease among infants and young children"},{"title3":"Influenza-associated morbidity and mortality in young and middle-aged women"},{"title3":"Administrative data accurately identified intensive care unit admissions in Ontario"},{"title3":"Ambulatory care groups: a categorization of diagnoses for research and management"},{"title3":"Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease"},{"title3":"Using OHIP physician billing claims to ascertain individual influenza vaccination status"}]},{"title2":"Obesity could shift severe COVID-19 disease to younger ages","References":[{"title3":"COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Americans are already too diseased to go back to work right now"},{"title3":"Global Health Obsevatory (GHO) data: overweight and obesity"},{"title3":"Impact of obesity on influenza A virus pathogenesis, immune response, and evolution"},{"title3":"Health effects of overweight and obesity in 195 countries over 25 years"}]},{"title2":"Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission","References":[]},{"title2":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","References":[]},{"title2":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","References":[{"title3":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China"},{"title3":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak"},{"title3":"Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City"},{"title3":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients"},{"title3":"COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020"},{"title3":"Crowdsourcing a crisis response for COVID-19 in oncology"},{"title3":"Research electronic data capture (REDCap):a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach"},{"title3":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors"},{"title3":"RegularIZation and variable selection via the elastic net"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Case fatality rate of cancer patients with COVID-19 in a New York hospital system"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2"},{"title3":"Phase I/II trial to evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with pancreatic cancer and an ECOG performance status of 2"},{"title3":"Facing Covid-19 in Italy - ethics, logistics, and therapeutics on the epidemic's front line"},{"title3":"Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic"},{"title3":"Inflammatory diseases of the lung induced by conventional cigarette smoke: a review"},{"title3":"Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review"},{"title3":"Sex difference and smoking predisposition in patients with COVID-19"},{"title3":"COVID-19 and smoking: a systematic review of the evidence"},{"title3":"Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2"},{"title3":"Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia"},{"title3":"TMPRSS2 and COVID-19: serendipity or opportunity for intervention?"},{"title3":"COVID-19 Response Team. Characteristics of health care personnel with COVID-19 - United States, February 12-April 9, 2020"},{"title3":"Effects of delayed surgical resection on short-term and long-term outcomes in clinical stage I non-small cell lung cancer"},{"title3":"Time to surgery and breast cancer survival in the United States"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19"}]},{"title2":"Clinical characteristics and outcomes of COVID-19 among patients with pre-existing liver disease in United States: a multi-center research network study","References":[]},{"title2":"Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a metaanalysis","References":[]},{"title2":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a metaanalysis","References":[{"title3":" Coronavirus Disease 2019 (COVID-19) Situation Report-63 "},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Intergovernmental Panel on Climate Change, ed"},{"title3":"Neutrophils and neutrophil-lymphocyte ratio: inflammatory markers associated with intimal-media thickness of atherosclerosis"},{"title3":"Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer"},{"title3":"Estimating the mean and variance from the median, range, and the size of a sample"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19"},{"title3":"The clinical and chest CT features associated with severe and critical COVID-19 pneumonia"}]},{"title2":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","References":[{"title3":"The neutrophil-to-lymphocyte ratio: a narrative review"},{"title3":"Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction"},{"title3":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer"},{"title3":"Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage"},{"title3":"Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severeacute-respiratoryinfection-when-novelcoronavirus-(ncov)-infection-is-suspected. (accessed March 29, 2020). 2020."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. https://www.whoint/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117(accessed March 29, 2020). 2020."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study"},{"title3":"Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"}]}]},{"title1":"Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, Washington","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Severe outcomes among patients with Coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Early epidemiological and clinical characteristics of 28 cases of coronavirus disease in South Korea","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","References":[{"title3":"A New Vision for the National Institutes of Health"},{"title3":"SQLGEN: a framework for rapid client-server database application development"},{"title3":"WebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databases"},{"title3":"Model-driven development of Web applications: the Auto Web system"},{"title3":"Value of Hosted Clinical Data Environments"},{"title3":"A comparison study: paper-based versus web-based data collection and management"}]},{"title2":"Clinical findings in 111 cases of influenza A (H7N9) virus infection","References":[]},{"title2":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"Comparative performance of SARS-CoV-2 detection assays using seven different primer/probe sets and one assay kit","References":[]},{"title2":"Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies","References":[]},{"title2":"Cryptic transmission of SARS-CoV-2 in Washington State","References":[{"title3":"A distinct name is needed for the new coronavirus"},{"title3":"A. Rambaut, Phylogenetic analysis of nCoV-2019 genomes (Virological, 2020); https://virological.org/t/phylodynamic-analysis-176-genomes-6-mar-2020/356."},{"title3":"World Health Organization (WHO), &quot;Coronavirus disease 2019 (COVID-19): Situation report - 55&quot; (WHO, 2020); www.who.int/docs/default-source/coronaviruse/situation-reports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_8."},{"title3":"F. Schlosser, B. F. Maier, O. Baranov, D. Brockmann, C. Jongen, A. Zachariae, A. Rose, Coronavirus COVID-19 Global Risk Assessment, Event Horizon - COVID-19 (2020); http://rocs.hu-berlin.de/corona/."},{"title3":"World Health Organization (WHO), &quot;Coronavirus disease 2019 (COVID-19): Situation report - 38&quot; (WHO, 2020); www.who.int/docs/default-source/coronaviruse/situation-reports/20200227-sitrep-38-covid-19.pdf?sfvrsn=2db7a09b_4."},{"title3":"K. Bray, &quot;Coronavirus update: Addressing questions about a presumptive positive case in an adolescent&quot; (Snohomish Health District Public Health Essentials, 2020); www.snohd.org/Blog.aspx?IID=13."},{"title3":"Washington State Department of Health, &quot;2019 Novel Coronavirus Outbreak (COVID-19)&quot; (2020); www.doh.wa.gov/Emergencies/Coronavirus."},{"title3":"GISAID: Global initiative on sharing all influenza data - from vision to reality"},{"title3":"Data, disease and diplomacy: GISAID's innovative contribution to global health"},{"title3":"The proximal origin of SARS-CoV-2"},{"title3":"N. Imai, I. Dorigatti, A. Cori, C. Donnelly, S. Riley, N. M. Ferguson, &quot;Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China&quot; (Imperial College London, 2020); http://hdl.handle.net/10044/1/77150."},{"title3":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology"},{"title3":"Viral phylodynamics"},{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Serial interval of novel coronavirus (COVID-19) infections"},{"title3":"A Smartphone-Driven Thermometer Application for Real-time Population- and Individual-Level Influenza Surveillance"},{"title3":"U.S. Centers for Disease Control and Prevention (CDC), &quot;Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV)&quot; (CDC Health Alert Network, 2020); https://emergency.cdc.gov/han/han00427.asp."},{"title3":"U.S. Centers for Disease Control and Prevention (CDC), &quot;Criteria to Guide Evaluation of Persons Under Investigation (PUI) for 2019-nCoV&quot; (CDC, 2020); https://web.archive.org/web/20200222215422/https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html."},{"title3":"Introductions and early spread of SARS-CoV-2 in the New York City area"},{"title3":"Coast-to-coast spread of SARS-CoV-2 during the early epidemic in the United States."},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)"},{"title3":"Nextstrain: Real-time tracking of pathogen evolution"},{"title3":"LB21. The Seattle Flu Study: A Community-Based Study of Influenza"},{"title3":"Rapid Metagenomic Next-Generation Sequencing during an Investigation of Hospital-Acquired Human Parainfluenza Virus 3 Infections"},{"title3":"Comparative genomic, transcriptomic, and proteomic reannotation of human herpesvirus 6"},{"title3":"Ultrasensitive Capture of Human Herpes Simplex Virus Genomes Directly from Clinical Samples Reveals Extraordinarily Limited Evolution in Cell Culture"},{"title3":"SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing"},{"title3":"M. Vasimuddin, S. Misra, H. Li, S. Aluru, &quot;Efficient architecture-aware acceleration of BWA-MEM for multicore systems,&quot; in 2019 IEEE International Parallel and Distributed Processing Symposium (IPDPS) (IEEE, 2019), pp. 314-324."},{"title3":"Prokka: Rapid prokaryotic genome annotation"},{"title3":"MAFFT multiple sequence alignment software version 7: Improvements in performance and usability"},{"title3":"IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies"},{"title3":"Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10"},{"title3":"Dating of the human-ape splitting by a molecular clock of mitochondrial DNA"},{"title3":"A. Doucet, N. de Freitas, N. Gordon, in Sequential Monte Carlo Methods in Practice. Statistics for Engineering and Information Science, A. Doucet, N. de Freitas, N. Gordon, Eds. (Springer, 2001), pp. 3-14."},{"title3":"Novel approach to nonlinear/non-Gaussian Bayesian state estimation"}]},{"title2":"Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease","References":[{"title3":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans."},{"title3":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans."},{"title3":"Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009."},{"title3":"Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009."},{"title3":"Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009."},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada."},{"title3":"Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009, July 2009-update, 7 July 2009."},{"title3":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand."},{"title3":"2000 CDC growth charts for the United States: Methods and development."},{"title3":"A SAS Program for CDC Growth Charts."},{"title3":"Assessment of child and adolescent overweight and obesity."},{"title3":"Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health."},{"title3":"Obesity: preventing and managing the global epidemic."},{"title3":"Severe Novel Influenza A (H1N1) Virus Infection in the United States, April-May 2009."},{"title3":"CDC protocol of realtime RTPCR for influenza A (H1N1)."},{"title3":"Prevalence of overweight and obesity in the United States, 1999-2004."},{"title3":"What do case-control studies estimate? Survey of methods and assumptions in published case-control research."},{"title3":"Essentials of Medical Statistics."},{"title3":"Introduction to Variance Estimation."},{"title3":"Impact of overweight and obesity on hospitalization: race and gender differences."},{"title3":"Obesity-related excess mortality rate in an adult intensive care unit: A risk-adjusted matched cohort study."},{"title3":"Effect of obesity on intensive care morbidity and mortality: a meta-analysis."},{"title3":"A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women."},{"title3":"Prevalence and trends in obesity among US adults, 1999-2008."},{"title3":"NCHS data brief no 1. Obesity among adults in the United States-no change since 2003-2004."}]},{"title2":"A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1)","References":[]},{"title2":"Diabetes mellitus, hypertension, and death among 32 patients with MERS-CoV infection, Saudi Arabia","References":[{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."},{"title3":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study."},{"title3":"Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia."},{"title3":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014."}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats","References":[]},{"title2":"On the use of corticosteroids for 2019-nCoV pneumonia","References":[{"title3":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]"},{"title3":"Use of corticosteroids in treating infectious diseases"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report"}]},{"title2":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","References":[]},{"title2":"Arguments in favour of remdesivir for treating SARS-CoV-2 infections","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"Emerging threats from zoonotic coronaviruses:from SARS and MERS to 2019-nCoV"},{"title3":"Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group. bioRxiv preprint doi: 10.1101/2020.02.07.937862."},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Chloroquine for the 2019 novel coronavirus"},{"title3":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f] [triazin-4-amino] adenine c-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses"},{"title3":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"First case of 2019 novel coronavirus in the United States"}]}]}]}